Table 1.
Frequency (%) | Univariate analysis | Multivariable logistic regression† | |||
---|---|---|---|---|---|
Intention | p-value | Yes vs. No | |||
Yes n = 2984 |
No n = 602 |
OR (95% CI) | |||
Mother’s information | |||||
Age group (years old) | |||||
23-35 | 1699 (47.4) | 1435 (84.5) | 264 (15.5) | 1.16 (0.90–1.50) | |
36-40 | 1292 (36.0) | 1086 (84.1) | 206 (15.9) | 0.001 | 1.22 (0.9–1.59) |
>40 | 595 (16.6) | 463 (77.8) | 132 (22.2) | Reference | |
Birthplace | |||||
Urban | 587 (16.4) | 496 (84.5) | 91 (15.5) | 0.397 | |
Rural | 2999 (83.6) | 2488 (83.0) | 511 (17.0) | ||
Current residing location | |||||
Urban | 1793 (50.0) | 1508 (84.1) | 285 (15.9) | 0.166 | |
Rural | 1793 (50.0) | 1476 (82.3) | 317 (17.17) | ||
Marital Status | |||||
Married | 3406 (95.0) | 2842 (83.4) | 564 (16.6) | 0.124 | |
Unmarried/Divorced/ Separated/Widowed |
180 (5.0) | 142 (78.9) | 38 (21.1) | ||
Highest education level | |||||
Primary school and below | 223 (6.2) | 152 (68.2) | 71 (31.8) | Reference | |
Secondary school | 2026 (56.5) | 1688 (83.3) | 338 (16.7) | 1.82 (1.30–2.55)*** | |
High school/technical secondary school | 982 (27.4) | 830 (84.5) | 152 (15.5) | p < .001 | 1.67 (1.15–2.43)** |
University and above | 355 (9.9) | 314 (88.5) | 41 (11.5) | 2.15 (1.33–3.46)** | |
Occupational types | |||||
Professional and managerial | 233 (6.5) | 202 (86.7) | 31 (13.3) | ||
General office worker/Service personnel | 499 (13.9) | 417 (83.6) | 82 (16.4) | ||
Industrial worker/Farmers/Others | 1274 (35.5) | 1045 (82.0) | 229 (18.0) | B | |
Individual business/Self-employed | 625 (17.4) | 532 (85.1) 788 (82.5) |
93 (14.9) | ||
Housewife/Unemployed | 955 (26.6) | 16.7 (17.5) | |||
Annual household income (CNY) | |||||
<50,000 | 1976 (55.1) | 1617 (81.8) | 359 (18.2) | 0.034 | Reference |
50,000–120,000 | 1610 (44.9) | 1087 (85.3) | 187 (14.7) | 1.00 (0.82–1.24) | |
>120,000 | 336 (9.4) | 280 (83.3) | 56 (16.7) | 0.77 (0.56–1.08) | |
Experience with cervical cancer | |||||
Ever knew anyone has had cervical cancer | |||||
Yes | 705 (19.7) | 604 (85.7) | 101 (14.3) | 0.056 | |
No | 2881 (80.3) | 2380 (82.6) | 501 (17.4) | ||
Daughter’s information | |||||
Age (years old) | |||||
6-8 | 858 (23.9) | 728 (84.8) | 130 (15.2) | ||
9-11 | 1489 (41.5) | 1245 (83.6) | 244 (16.4) | 0.127 | |
12-14 | 1239 (34.6) | 1011 (81.6) | 228 (18.4) | ||
Had chronic illnesses | |||||
Yes | 80 (2.2) | 72 (90.0) | 594 (16.9) | 0.129 | |
No | 3506 (97.8) | 2912 (83.1) | 8 (10.0) | ||
Ever experienced serious side effects in any previous vaccinations | |||||
Yes | 326 (9.1) | 283 (86.8) | 43 (13.2) | 0.074 | |
No | 3260 (90.9) | 2701 (82.9) | 559 (17.1) | ||
HPV-related knowledge | |||||
Total knowledge score | |||||
Low score (0–10) | 1833 (51.1) | 1450 (79.1) | 383 (20.9) | p < .001 | Reference |
High score (11–23) | 1753 (48.9) | 1534 (87.5) | 219 (12.5) | 1.14 (0.92–1.40) | |
Health Beliefs | |||||
Perceived susceptibility | |||||
Women in general have a high risk of contracting HPV in their lifetime | |||||
Agree | 2811 (78.4) | 2412 (85.8) | 389 (14.2) | p < .001 | 1.26 (0.98–1.63) |
Disagree | 775 (21.6) | 572 (73.8) | 203 (26.2) | Reference | |
Women in general have a high risk of having genital warts in their lifetime | |||||
Agree | 2368 (66.0) | 2040 (86.1) | 328 (13.9) | p < .001 | 1.12 (0.89–1.41) |
Disagree | 1218 (34.0) | 944 (77.5) | 274 (22.5) | Reference | |
Women in general have a high risk of having cervical/vulvar cancer in their lifetime | |||||
Agree | 2722 (75.9) | 2334 (85.7) | 388 (14.3) | p < .001 | 1.22 (0.95–1.57) |
Disagree | 864 (24.1) | 650 (75.2) | 214 (24.8) | Reference | |
Perceived severity | |||||
Harms of HPV infection for women are severe | |||||
Agree | 3278 (91.4) | 2771 (84.5) | 507 (15.5) | 0.88 (0.60–1.30) | |
Disagree | 308 (8.6) | 213 (69.2) | 95 (30.8) | p < .001 | Reference |
Harms of genital warts for women are severe | |||||
Agree | 3258 (90.9) | 2757 (84.6) | 501 (15.4) | 1.05 (0.73–1.52) | |
Disagree | 328 (9.1) | 227 (69.2) | 101 (30.8) | p < .001 | Reference |
Harms of cervical/vulvar cancer for women are severe | |||||
Agree | 3371 (94.0) | 2845 (84.4) | 526 (15.6) | p < .001 | 1.21 (0.79–1.86) |
Disagree | 215 (6.0) | 139 (64.7) | 76 (35.3) | Reference | |
Perceived benefit | |||||
HPV vaccines are highly effective in preventing your daughter from HPV infection | |||||
Agree | 3034 (84.6) | 2638 (86.9) | 396 (13.1) | p < .001 | 2.13 (1.51–2.99)*** |
Disagree | 552 (15.4) | 346 (62.7) | 206 (37.3) | Reference | |
HPV vaccines are highly effective in preventing your daughter from genital warts | |||||
Agree | 2779 (77.5) | 2419 (87.0) | 360 (13.0) | p < .001 | 1.17 (0.87–1.58) |
Disagree | 807 (22.5) | 565 (70.0) | 242 (30.0) | Reference | |
HPV vaccines are highly effective in preventing your daughter from cervical/vulvar cancer | |||||
Agree | 2955 (82.4) | 2567 (86.9) | 388 (13.1) | p < .001 | 1.38 (0.99–1.92) |
Disagree | 631 (17.6) | 417 (66.1) | 214 (33.9) | Reference | |
Perceived barriers | |||||
It is not worth spending money to have my daughter vaccinated | |||||
Agree | 1057 (29.5) | 895 (84.7) | 162 (15.3) | 0.142 | |
Disagree | 2529 (70.5) | 2089 (82.6) | 440 (17.4) | ||
Do not have time to take my daughter for HPV vaccination | |||||
Agree | 683 (19.0) | 547 (80.1) | 136 (19.9) | 0.017 | Reference |
Disagree | 2903 (81.0) | 2437 (83.9) | 466 (16.1) | 1.37 (1.10–1.71)** | |
My daughter would have severe side effects after receiving HPV vaccination | |||||
Agree | 545 (15.2) | 452 (82.9) | 93 (17.1) | 0.852 | |
Disagree | 3041 (84.8) | 2532 (83.3) | 509 (16.7) | ||
Receiving HPV vaccination would increase my daughter’s risk of having juvenile sexual acts | |||||
Agree | 902 (25.2) | 755 (83.7) | 147 (16.3) | 0.681 | |
Disagree | 2684 (74.8) | 2229 (83.0) | 455 (17.0) | ||
Cues-to-action | |||||
You are often exposed to HPV vaccination promotion for adolescents on mass media | |||||
Agree | 1069 (29.8) | 927 (86.7) | 142 (13.3) | p < .001 | 1.18 (0.95–1.47) |
Disagree | 2517 (70.2) | 2057 (81.7) | 460 (18.3) | Reference |
**p < 0.01, ***p < 0.001
†Hosmer & Lemeshow test, chi-square:12.525, P-value: 0.129; Nagelkerke R2: 0.107